acetaZOLAMIDE (Rx)
(a-set-a-zole′a-mide)
Func. class.: Diuretic, carbonic anhydrase inhibitor, antiglaucoma agent, antiepileptic
Chem. class.: Sulfonamide derivative
USES: Open-angle glaucoma, angle-closure glaucoma (preoperatively, if surgery delayed), mixed, tonic-clonic, myoclonic, refractory seizures, epilepsy (petit mal, grand mal, absence), edema in HF, product-induced edema, acute altitude sickness
CONTRAINDICATIONS: Hypersensitivity to sulfonamides, severe renal/hepatic disease, electrolyte imbalances (hyponatremia, hypokalemia), hyperchloremic acidosis, Addison's disease, long-term use for closed-angle glaucoma, adrenocortical insufficiency, metabolic acidosis, acidemia, anuria
Angle-closure glaucoma
Adult: PO/IV 250 mg q4hr or 250 mg bid for short-term therapy
Chronic open-angle glaucoma
Adult: PO/IV 250 mg 1-4 times per day or 500 mg EXTENDED RELEASE bid, max 1 g/day
Child (unlabeled): PO 8-30 mg/kg/day in divided doses tid or qid, or 300-900 mg/m2/day, max 1 g/day; IV 5-10 mg q6hr, max 1 g/day
Edema in heart failure, drug-induced edema
Adult: PO/IV 250-375 mg/day
Child (unlabeled): PO/IV 5 mg/kg/day or 150 mg/m2 in AM
Adjunct for epilepsy and myoclonic, refractory, generalized tonic-clonic, absence or mixed seizures
Adult: PO/IV 8-30 mg/kg/day in 1-4 divided doses, usual range 375-1000 mg/day; EXTENDED RELEASE not recommended with seizures
Altitude sickness
Adult: PO 250 mg twice daily starting the day before ascent and continuing for 2 to 3 days after reaching the target altitude or until descent is initiated
Renal dose
Adult: PO/IV CCr 50-80 mL/min give dose q6hr regular release or IV; CCr 10-50 mL/min give dose q12hr; CCr 10 mL/min, avoid use
acetylcholine ophthalmic
See Appendix B
acetylcysteine (Rx)
(a-se-teel-sis′tay-een)
Acetadote, Mucomyst
Func. class.: Mucolytic; antidote-acetaminophen
Chem. class.: Amino acid l-cysteine
ACTION: Decreases viscosity of secretions by breaking disulfide links of mucoproteins; serves as a substrate in place of glutathione, which is necessary to inactivate toxic metabolites with acetaminophen overdose
USES:Acetaminophen toxicity; bronchitis; cystic fibrosis; COPD; atelectasis
Unlabeled uses: Prevention of contrast medium nephrotoxicity
CONTRAINDICATIONS: Hypersensitivity
Precautions: Pregnancy, breastfeeding, hypothyroidism, Addison's disease, CNS depression, brain tumor, asthma, renal/hepatic disease, COPD, psychosis, alcoholism, seizure disorders, bronchospasms, anaphylactoid reactions, fluid restriction, weight <40 kg, increased intracranial pressure, status asthmaticus
Acetaminophen toxicity
Adult and child: PO 140 mg/kg, then 70 mg/kg q4hr × 17 doses to total of 1330 mg/kg; ≥41-100 kg IV loading dose 150 mg/kg over 60 min (dilution 150 mg/kg in 200 mL of D5W); then 50 mg/kg over 4 hr (dilution 50 mg/kg in 500 mL D5W); then 100 mg/kg over 16 hr (dilution 100 mg/kg in 1000 D5W)
Adult/child 21-40 kg: IV 150 mg/kg in 100 mL diluent over 1 hr, then 50 mg/kg in 250 mL over 4 hr, then 100 mg/kg in 500 mg over 16 hr
Infant/child 5-20 kg: IV 150 mg/kg in 3 mL/kg diluent over 1 hr, then 50 mg/kg in 7 mL/kg diluent over 4 hr, then 100 mg/kg in 14 mL/kg diluent over 16 hr
Mucolytic
Adult and child 1-12 yr: INSTILL 1-2 mL (10%-20% solution) q6-8hr prn or 3-5 mL (20% solution) or 6-10 mL (10% sol) tid or qid; NEBULIZER (face mask, mouthpiece, tracheostomy) 1-10 mL of a 20% sol, or 2-20 mL of a 10% sol, q2-8hr; NEBULIZER (tent, croupette) may require large dose, up to 300 mL/treatment
Tracheostomy care
Adult/child: INSTILL 1-2 mL (10%-20% sol) q1-4hr directly into tracheostomy
Diagnostic bronchial lab studies
Adult/child: NEBULIZER 2-3 uses of 1-2 mL of 20% sol or 2-4 mL of 10% sol
Prevention of radiocontrast-induced renal reactions (unlabeled)
Adult: PO 600 mg bid × 2 days before radiocontrast
Available forms: Oral solution 10%, 20%; inj 20% (200 mg/mL); effervescent tablet for oral solution 500, 2500 mg
Administer:
PO route
Antidotal use: give within 8 hr for best results; dilute 10% or 20% solution to a 5% solution with diet soda, may use water if giving via gastric tube; dilution of 10% solution 1:1, 20% sol 1:3, store open undiluted solution refrigerated ≤96 hr, repeat dose if vomited within 1 hr
PO route (effervescent tablets for oral solution)
Dissolve in 100 mL water (50 mg/mL) 1-19 kg; in 150 mL water 20-59 kg; 300 mg/mL ≥60 kg
Direct intratracheal instill route
By syringe: 1-2 mL of 10%-20% solution up to q1hr
Decreased dose to geriatric patients; metabolism may be slowed
Only if suction machine is available
Only after patient clears airway by deep breathing, coughing
Assistance with inhaled dose: bronchodilator if bronchospasm occurs; mechanical suction if cough insufficient to remove excess bronchial secretions
IV route
21-hr regimen: loading dose: dilute 150 mg/kg in 200 mL D5W; maintenance dose 1: dilute 50 mg/kg in 500 mL D5W; maintenance dose 2: dilute 100 mg/kg in 1000 mL D5W; give loading dose over 15 min; give maintenance dose 1 over 4 hr; give maintenance dose 2 over 16 hr, administer sequentially without time between doses
Store in refrigerator; use within 96 hr of opening
CNS:Dizziness, drowsiness,fever, chills
CV: Edema, flushing tachycardia
EENT:Rhinorrhea,pharyngitis
GI:Nausea,stomatitis, vomiting, anorexia
INTEG:Urticaria, rash, clamminess, pruritus
RESP:Bronchospasm, chest tightness, cough, dyspnea
MISC:Anaphylaxis, angioedema, unpleasant odor
Side effects: italics = common;red = life-threatening
IV: Excreted in urine, half-life 5.6 hr (adult), 11 hr (newborn), protein binding 83%, peak up to 60 min (PO), 5-10 min (INH)
Mucolytic use: cough-type, frequency, character, including sputum; bronchospasm
Rate, rhythm of respirations, increased dyspnea; sputum; discontinue if bronchospasm occurs
VS, cardiac status including checking for dysrhythmias, increased rate, palpitations
ABGs for increased CO2 retention in asthma patients
Antidotal use: use within 24 hr of acetaminophen toxicity, give within 10 hr of acetaminophen to minimize hepatotoxicity; monitor LFTs, PT, BUN, creatinine, glucose, electrolytes, acetaminophen levels; inform prescriber if dose is vomited or if vomiting is persistent; 150 mg/kg may be toxic, check acetaminophen level q4hr
Hypersensitivity: anaphylaxis may occur with IV dose; if present, stop infusion, treat, restart; assess for dyspnea, swelling of face, lips, tongue; rash, itching
Nausea, vomiting, rash; notify prescriber if these occur
Pregnancy/breastfeeding: use only if clearly needed; cautious use in breastfeeding, excretion unknown
Therapeutic response: absence of purulent secretions when coughing, clear lung sounds (mucolytic use); absence of hepatic damage with acetaminophen toxicity
That foul odor and smell may be unpleasant
To clear airway for inhalation
To report vomiting because dose may need to be repeated
Acetaminophen toxicity: Explain reason for product, expected result